Cancer is often detected too late. At Exact Sciences, we are committed to using our expertise and determination to help detect cancer earlier. Collaborating with Mayo Clinic, Exact Sciences developed Cologuard, the first and only FDA-approved stool DNA screening for colorectal cancer. In the past 10 years, we’ve grown from a small team to more than 2,300 people working to develop life-changing innovations in earlier cancer detection.

  • Diagnosis and Treatment of Cancer and Other Diseases

  • Transforming Healthcare Deliveries and Improving the Standards of Care